Silvan Turkcan

Stock Analyst at Citizens

(0.39)
# 4,980
Out of 5,122 analysts
1
Total ratings
n/a
Success rate
-1.24%
Average return
Main Sectors:
Top Industries:

Stocks Rated by Silvan Turkcan

CRISPR Therapeutics AG
Jan 30, 2026
Maintains: Market Outperform
Price Target: $86$80
Current: $52.00
Upside: +53.85%